Loading...
Zoetis Inc.
ZTS•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$155.44
$-1.79(-1.14%)
Zoetis Inc. (ZTS) Financial Performance & Statements
Review Zoetis Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.33%
↑ 8.33%
Operating Income Growth
10.52%
↑ 10.52%
Net Income Growth
6.06%
↑ 6.06%
Operating Cash Flow Growth
25.50%
↑ 25.50%
Operating Margin
37.01%
↑ 37.01%
Gross Margin
70.20%
↑ 70.20%
Net Profit Margin
27.12%
↑ 27.12%
ROE
51.32%
↑ 51.32%
ROIC
32.08%
↑ 32.08%
Zoetis Inc. (ZTS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Zoetis Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.32B | $2.39B | $2.36B | $2.19B |
| Cost of Revenue | $707.00M | $701.00M | $703.00M | $680.00M |
| Gross Profit | $1.61B | $1.69B | $1.66B | $1.51B |
| Gross Profit Ratio | $0.69 | $0.71 | $0.70 | $0.69 |
| R&D Expenses | $186.00M | $167.00M | $171.00M | $162.00M |
| SG&A Expenses | $625.00M | $565.00M | $581.00M | $547.00M |
| Operating Expenses | $845.00M | $732.00M | $752.00M | $709.00M |
| Total Costs & Expenses | $1.55B | $1.47B | $1.46B | $1.39B |
| Interest Income | $27.00M | $23.00M | $24.00M | $32.00M |
| Interest Expense | $51.00M | $57.00M | $59.00M | $58.00M |
| Depreciation & Amortization | $123.00M | $121.00M | $127.00M | $126.00M |
| EBITDA | $911.00M | $1.06B | $1.03B | $927.00M |
| EBITDA Ratio | $0.39 | $0.44 | $0.44 | $0.42 |
| Operating Income | $765.00M | $920.00M | $906.00M | $801.00M |
| Operating Income Ratio | $0.33 | $0.39 | $0.38 | $0.37 |
| Other Income/Expenses (Net) | -$33.00M | -$46.00M | -$161.00M | -$91.00M |
| Income Before Tax | $732.00M | $874.00M | $780.00M | $747.00M |
| Income Before Tax Ratio | $0.32 | $0.37 | $0.33 | $0.34 |
| Income Tax Expense | $151.00M | $182.00M | $156.00M | $148.00M |
| Net Income | $581.00M | $682.00M | $624.00M | $599.00M |
| Net Income Ratio | $0.25 | $0.29 | $0.26 | $0.27 |
| EPS | $1.28 | $1.51 | $1.37 | $1.31 |
| Diluted EPS | $1.28 | $1.50 | $1.37 | $1.31 |
| Weighted Avg Shares Outstanding | $450.50M | $452.90M | $455.50M | $458.00M |
| Weighted Avg Shares Outstanding (Diluted) | $451.10M | $453.50M | $456.00M | $458.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan